Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions (TAMARIS)
This study is ongoing, but not recruiting participants.
Study NCT00566657   Information provided by Sanofi-Aventis
First Received: November 30, 2007   Last Updated: August 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Peripheral Vascular Diseases
Additional conditions recognized in this trial
Ischemia
Vascular Diseases
More general conditions related to this trial
Cardiovascular Diseases
Pathologic Processes
Interventions listed in this trial
XRP0038/NV1FGF
placebo
Sponsors listed in this trial
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services